I posted the link to the Nasdaq rule that states they must give 15 days prior notice before it goes into effect..
I posted the link to the Nasdaq Stock Split Calendar so you or anyone can see when its coming
I posted the rules on being Nasdaq delinquent and how after 30 days they can file for a 180 day extension...
I post that Nasdaq and NYES have halted the de listing while the pandemic is still going on...
I have give all the people who read here facts as to why there is no RS coming..
You and you helper there, new new IHUB know it all's have posted nothing but one thing... RS RS RS RS ...you sound like chicken little running around... your our comic relief while we wait on the Meric collaboration news.
Recent INDP News
- Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference • GlobeNewswire Inc. • 03/28/2024 12:00:00 PM
- Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 03/25/2024 12:30:00 PM
- Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024 • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/13/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 04:01:33 PM
- Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort • GlobeNewswire Inc. • 03/04/2024 12:30:00 PM
- Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:15:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:05:34 PM
- European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 09:06:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:05:38 PM
- Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/06/2023 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 01:13:21 PM
- Indaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune Response of More than Fifty Cytokines and Chemokines in Patients Following a Single Dose in First Cohort of Ongoing Phase 1 Study • GlobeNewswire Inc. • 11/06/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 01:12:31 PM
- Indaptus Therapeutics to Present Positive Pharmacodynamic (PD) Immune and Pharmacokinetic (PK) Results with Patients from First Cohort of Ongoing Phase 1 Study of Decoy20 at Cancer Immunotherapy Meeting • GlobeNewswire Inc. • 10/31/2023 01:01:00 PM
- Indaptus Therapeutics to Present at the LD Micro Main Event XVI • GlobeNewswire Inc. • 09/27/2023 12:00:00 PM
- Registration Is Now Open For Tribe Public’s Webinar Event "Immunotherapy Reimagined" Featuring Indaptus Therapeutics’ CEO On Friday, September 29, 2023 • GlobeNewswire Inc. • 09/26/2023 12:00:00 PM
- Indaptus Therapeutics Doses First Patient in Second Cohort of Single Dose Ranging Study of Decoy20 • GlobeNewswire Inc. • 09/19/2023 12:00:00 PM
- Indaptus Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2023 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 10:01:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 12:15:33 PM
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM